VTVT - vTv Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue12,434291634519
Cost of Revenue23,03539,64045,74829,584
Gross Profit-10,601-39,349-45,114-29,065
Operating Expenses
Research Development-39,64039,64039,640
Selling General and Administrative9,22311,3339,9069,077
Non Recurring----
Others----
Total Operating Expenses32,25850,97355,65438,661
Operating Income or Loss-19,824-50,682-55,020-38,142
Income from Continuing Operations
Total Other Income/Expenses Net-3,821-3,165-333-2,965
Earnings Before Interest and Taxes-19,824-50,682-55,020-38,142
Interest Expense-3,290-3,092-398-1,775
Income Before Tax-23,645-53,847-55,353-41,107
Income Tax Expense200800--
Minority Interest62,482131,440122,515161,531
Net Income From Continuing Ops-23,845-54,647-55,353-41,107
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-7,911-16,144-16,352-27,498
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,650-16,144-16,352-27,498